Newer Long-Acting Insulins: A Physiologic Approach to Glucose Control

Newer Long-Acting Insulins: A Physiologic Approach to Glucose Control is organized by Pri-Med and will be held from Jul 16, 2018 - Jul 17, 2019.

Credits:
0.50 AMA PRA Category 1 Credits™ or 0.55 AANP, including 0.33 AANP Pharm

 

Overview :
This case examines the management of a patient experiencing episodes of nocturnal hypoglycemia on premixed and prandial insulin. Areas of concentration include switching to ultra-long-acting basal insulin (including dose conversions), hypoglycemia self-management, depression and anxiety in patients with diabetes, and lipodystrophy. 

Learning Objectives :
• Identify and overcome barriers towards appropriate use of insulin in order to optimize treatment and increase patient adherence to insulin therapy
• Distinguish among traditional and newer long-acting basal insulin products, with relation to pharmacokinetic/pharmacodynamic properties, glycemic variability, and risk profile, and identify patients who would benefit from newer long-acting basal insulin
• Delineate best practices to individualize newer long-acting insulin therapy for patients with T2DM and minimize the risk of hypoglycemia

Additional details will be posted as soon as they are available.